Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma

Summary

This study is a single-center, prospective, one-arm clinical study, which is planned to be carried out in Cancer Hospital of Chinese Academy of Medical Sciences. The patients with locally advanced or metastatic leiomyosarcoma who are inoperable are enrolled, aiming at the effectiveness and safety of temozolomide for injection combined with epirubicin as the first-line treatment for advanced leiomyosarcoma.

Timeline

Start

2021-08-27

Primary completion

2022-08-27

Completion

2023-08-27

Drugs

Indications